×

Biotech stocks exposed to Hillary's plan

12:11 PM ET Tue, 22 Sept 2015

Discussing the hit to biotech after Hillary Clinton criticized drug price gouging, with Mark Schoenebaum, Evercore ISI head of Health Care Research Team